Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Technique Reduces Pneumothorax Treatment Pain

By HospiMedica International staff writers
Posted on 12 Oct 2015
Analyzing the partial pressure of oxygen (O2) and carbon dioxide (CO2) during pneumothorax treatment helps reduce the resulting pain, according to a new study.

Researchers at Tianjin Chest Hospital (China) conducted a study involving 49 patients, monitoring pneumothorax conditions in real time by analyzing thoracic cavity gas during treatment in order to provide instructions for updating treatment strategy. More...
To do so, they monitored partial pressures of O2 and CO2 in the thoracic cavity before and during treatment, and after chest tube clogging. Pneumothorax type was then diagnosed according to the partial pressure results, and the treatment strategy was updated accordingly.

Accordingly, the patients were divided into four groups; group A, consisting of 30 patients with a closed pneumothorax; group B, consisting of 10 patients with open pneumothorax; Group C, with 3 patients with tension pneumothorax; and Group D, consisting of 6 patients with closed pneumothorax who were re-diagnosed to have open pneumothorax upon second analysis. The cure rates of the four groups after treatment were as follows: Group A (97%), Group B (100%), Group C (100%) and Group D (100%). The study was published on August 6, 2015, in Technology.

“It is very important to design the optimal treatment strategy according to the actual severity status of the pneumothorax. However, the actual status in the chest cavity may not keep unchanged during the management of the pneumothorax,” said lead author Prof. Yuechuan Li, MD, chief physician in Tianjin Chest Hospital. “The most frequent complication associated with chest tubes is chest tube clogging. We have found that after remove the clogged chest tube, in many cases, we could use a less painful needle aspiration because the pneumothorax has changed to a closed pneumothorax.”

“By analyzing the thoracic cavity gas in real time, the partial pressure of carbon dioxide and oxygen, during the pneumothorax treatment, the therapeutic strategy is updated accordingly,” added study coauthor Said Hui Ma, MD. “In many cases, the following-up treatment can be updated to less painful management method, such as conservative management, or updated to needle aspiration instead of continue using chest tube drainage.”

Primary spontaneous pneumothorax is an abnormal accumulation of air in the pleural space that can result in the partial or complete collapse of a lung. It is likely due to the formation of small sacs of air (blebs) in lung tissue that rupture, causing air to leak into the pleural space, creating pressure that is manifest as chest pain on the side of the collapsed lung and shortness of breath. Often, people who experience a primary spontaneous pneumothorax have no prior sign of illness; the blebs themselves typically do not cause any symptoms and are visible only on medical imaging.

Related Links:

Tianjin Chest Hospital



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.